220 related articles for article (PubMed ID: 36246147)
21. A systematic review of validated methods for identifying patients with rheumatoid arthritis using administrative or claims data.
Chung CP; Rohan P; Krishnaswami S; McPheeters ML
Vaccine; 2013 Dec; 31 Suppl 10():K41-61. PubMed ID: 24331074
[TBL] [Abstract][Full Text] [Related]
22. Analgesic prescribing in patients with inflammatory arthritis in England: an observational study using electronic healthcare record data.
Scott IC; Bailey J; White CR; Mallen CD; Muller S
Rheumatology (Oxford); 2022 Aug; 61(8):3201-3211. PubMed ID: 34849617
[TBL] [Abstract][Full Text] [Related]
23. Psychometric properties of the painDETECT questionnaire in rheumatoid arthritis, psoriatic arthritis and spondyloarthritis: Rasch analysis and test-retest reliability.
Rifbjerg-Madsen S; Wæhrens EE; Danneskiold-Samsøe B; Amris K
Health Qual Life Outcomes; 2017 May; 15(1):110. PubMed ID: 28532452
[TBL] [Abstract][Full Text] [Related]
24. Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study.
Paalanen K; Puolakka K; Nikiphorou E; Hannonen P; Sokka T
Rheumatology (Oxford); 2021 May; 60(5):2391-2395. PubMed ID: 33175968
[TBL] [Abstract][Full Text] [Related]
25. Pain catastrophizing in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: biopsychosocial perspective and impact on health-related quality of life.
Wilk M; Łosińska K; Pripp AH; Korkosz M; Haugeberg G
Rheumatol Int; 2022 Apr; 42(4):669-682. PubMed ID: 35098329
[TBL] [Abstract][Full Text] [Related]
26. High disease relapse after bDMARD spacing in psoriatic arthritis compared to rheumatoid arthritis and axial spondyloarthritis patients: real-life data from BIOPURE registry.
Fornaro M; Righetti G; Abbruzzese A; Lopalco G; Cacciapaglia F; Anelli MG; Venerito V; Iannone F
Clin Rheumatol; 2021 Sep; 40(9):3659-3665. PubMed ID: 33864158
[TBL] [Abstract][Full Text] [Related]
27. Incidence, sociodemographic factors and treatment penetration of rheumatoid arthritis and psoriatic arthritis in Norway.
Kerola AM; Sexton J; Wibetoe G; Rollefstad S; Crowson CS; Mars N; Kazemi A; Haavardsholm EA; Kvien TK; Semb AG
Semin Arthritis Rheum; 2021 Oct; 51(5):1081-1088. PubMed ID: 34450506
[TBL] [Abstract][Full Text] [Related]
28. Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries.
Egeberg A; Rosenø NAL; Aagaard D; Lørup EH; Nielsen ML; Nymand L; Kristensen LE; Thyssen JP; Thomsen SF; Cordtz RL; Loft N; Skov L; Bryld LE; Rasmussen MK; Højgaard P; Kristensen S; Dreyer L
Semin Arthritis Rheum; 2022 Apr; 53():151979. PubMed ID: 35183936
[TBL] [Abstract][Full Text] [Related]
29. Comparison of Rheumatoid Arthritis Information Recorded in UK CPRD Aurum and CPRD GOLD Databases (Companion Paper 3).
Vasilakis-Scaramozza C; Hagberg KW; Persson R; Kafatos G; Maskell J; Neasham D; Jick S
Clin Epidemiol; 2023; 15():1207-1218. PubMed ID: 38126003
[TBL] [Abstract][Full Text] [Related]
30. Incidence and Management of Cardiovascular Risk Factors in Psoriatic Arthritis and Rheumatoid Arthritis: A Population-Based Study.
Jafri K; Bartels CM; Shin D; Gelfand JM; Ogdie A
Arthritis Care Res (Hoboken); 2017 Jan; 69(1):51-57. PubMed ID: 27696731
[TBL] [Abstract][Full Text] [Related]
31. Axial involvement according to ASAS criteria in an observational psoriatic arthritis cohort.
Carvalho PD; Savy F; Moragues C; Juanola X; Rodriguez-Moreno J
Acta Reumatol Port; 2017; 42(2):176-182. PubMed ID: 28693033
[TBL] [Abstract][Full Text] [Related]
32. Golimumab in real-life settings: 2 Years drug survival and predictors of clinical outcomes in rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis.
Iannone F; Santo L; Anelli MG; Bucci R; Semeraro A; Quarta L; D'Onofrio F; Marsico A; Carlino G; Casilli O; Cacciapaglia F; Zuccaro C; Falappone PC; Cantatore FP; Muratore M; Lapadula G
Semin Arthritis Rheum; 2017 Aug; 47(1):108-114. PubMed ID: 28216195
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of Rheumatoid Arthritis and Spondyloarthritis in Turkey: A Nationwide Study.
Tuncer T; Gilgil E; Kaçar C; Kurtaiş Y; Kutlay Ş; Bütün B; Yalçin P; Akarirmak Ü; Altan L; Ardiç F; Ardiçoğlu Ö; Altay Z; Cantürk F; Cerrahoğlu L; Çevik R; Demir H; Durmaz B; Dursun N; Duruöz T; Erdoğan C; Evcik D; Gürsoy S; Hizmetli S; Kaptanoğlu E; Kayhan Ö; Kirnap M; Kokino S; Kozanoğlu E; Kuran B; Nas K; Öncel S; Sindel D; Orkun S; Sarpel T; Savaş S; Şendur ÖF; Şenel K; Uğurlu H; Uzunca K; Tekeoğlu İ; Guillemin F
Arch Rheumatol; 2018 Jun; 33(2):128-136. PubMed ID: 30207568
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated.
Raadsen R; Hansildaar R; Pouw LC; Hooijberg F; Boekel L; Wolbink GJ; van Kuijk AWR; Nurmohamed MT
RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053460
[TBL] [Abstract][Full Text] [Related]
35. JAK inhibitors, psoriatic arthritis, and axial spondyloarthritis: a critical review of clinical trials.
Keeling S; Maksymowych WP
Expert Rev Clin Immunol; 2021 Jul; 17(7):701-715. PubMed ID: 33944642
[TBL] [Abstract][Full Text] [Related]
36. Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis.
Jarlborg M; Courvoisier DS; Lamacchia C; Martinez Prat L; Mahler M; Bentow C; Finckh A; Gabay C; Nissen MJ;
Arthritis Res Ther; 2020 May; 22(1):105. PubMed ID: 32375861
[TBL] [Abstract][Full Text] [Related]
37. Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project.
Castañeda S; González C; Villaverde V; Lajas Petisco C; Castro MC; Jirout F; Obaya JC; Hermosa JC; Suárez C; García S; Rodero M; León L; López Esteban A; Gobbo M; Alcaide L; Torre-Alonso JC
Reumatol Clin (Engl Ed); 2022 Feb; 18(2):114-123. PubMed ID: 35153034
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of anxiety and depression and the association with self-management behaviour in >12 000 patients with inflammatory rheumatic disease: a cross-sectional nationwide study.
Vestergaard SB; Esbensen BA; Klausen JM; Glintborg B; Lau L; Yilmaz Jantzen C; Aadahl M; Fevejle Cromhout P; de Thurah A
RMD Open; 2024 Jan; 10(1):. PubMed ID: 38253596
[TBL] [Abstract][Full Text] [Related]
39. Axial Disease in Psoriatic Arthritis study: defining the clinical and radiographic phenotype of psoriatic spondyloarthritis.
Jadon DR; Sengupta R; Nightingale A; Lindsay M; Korendowych E; Robinson G; Jobling A; Shaddick G; Bi J; Winchester R; Giles JT; McHugh NJ
Ann Rheum Dis; 2017 Apr; 76(4):701-707. PubMed ID: 27913376
[TBL] [Abstract][Full Text] [Related]
40. Healthcare and burden of disease in psoriatic arthritis. A comparison with rheumatoid arthritis and ankylosing spondylitis.
Zink A; Thiele K; Huscher D; Listing J; Sieper J; Krause A; Gromnica-Ihle E; von Hinueber U; Wassenberg S; Genth E; Schneider M;
J Rheumatol; 2006 Jan; 33(1):86-90. PubMed ID: 16395755
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
